| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.887985 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240905090956 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 200603t20202020onc ob f00| 0 eng d |
|---|
| 020 | |a9780660351179 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH139-17/2020E-PDF |
|---|
| 245 | 00|aAnnex 7 to the Good manufacturing practices guide for drugs products : |bselected non-prescription drugs. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (25 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Annexe 7 du Guide sur les bonnes pratiques de fabrication des drogues : lignes directrices sur certains médicaments en vente libre. |
|---|
| 500 | |a"GUI-0066." |
|---|
| 500 | |a"August 2020." |
|---|
| 500 | |a"Replaces: Annex 1 to the Current Edition of the Good Manufacturing Practices Guidelines – Selected Category IV Monograph Drugs (GUI-0066) June 10 2011." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (page 24-25). |
|---|
| 650 | 0|aNonprescription drug industry|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tAnnexe 7 du Guide sur les bonnes pratiques de fabrication des drogues : |w(CaOODSP)9.887986 |
|---|
| 794 | |tAnnex 7 to the Good manufacturing practices guide : |w(CaOODSP)9.895273 |
|---|
| 856 | 40|qPDF|s998 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H139-17-2020-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-7-good-manufacturing-practices-guide-drug-products-selected-non-prescription-drugs-0066.html |
|---|
| 986 | |a200065 |
|---|